Preventing drug driving in Europe: policy measures for national and EU action

This report aims to provide a summary of drug driving across Europe, drawing on the latest research to provide an overview of how drugs affect collision risk and the prevalence of different types of drugs in different road users and regions. It summarises various approaches to combating drug driving from around Europe and the ways in which they can be used to help tackle both drug driving itself and other underlying issues related to drug use. Most countries already have legislation in place to deal with illicit drugs and many have introduced legislation directly aimed at drug driving. These vary in form depending on the type of drug (illicit/licit) and different penalties apply depending on the type used and the severity of impairment. Improvements in detection equipment have helped lead to more accurate methods of screening and identifying specific substances. Educational and awareness campaigns are used by many countries to highlight the dangers of driving under the influence of psychoactive drugs and to educate the public about the effects they can have and the consequences drug driving can lead to. These approaches can be targeted at those groups amongst which drug driving is known to be prevalent. Rehabilitation and healthcare provide pathways for offenders to return to driving while also helping to reduce the likelihood of recidivism. Schemes vary from country to country and by the type of offender. Some forms of rehabilitation are handled primarily by driver licensing authorities, whereas others are more healthcare oriented. Recommendations have been made here based on those countermeasures and approaches shown to be most effective


  • English

Media Info

  • Pagination: 23p

Subject/Index Terms

Filing Info

  • Accession Number: 01632532
  • Record Type: Publication
  • Source Agency: ARRB
  • Files: ATRI
  • Created Date: Apr 24 2017 10:22AM